STOCKHOLM--(BUSINESS WIRE)--Regulatory News:
Moberg Derma AB (STO:MOB):
FIRST QUARTER (JAN-MAR 2012)
· Revenue MSEK 31.0 (5.5)
· Research and development expenses MSEK 7.9 (6.6)
STOCKHOLM--(BUSINESS WIRE)--Regulatory News:
Moberg Derma AB (STO:MOB):
FIRST QUARTER (JAN-MAR 2012)
· Revenue MSEK 31.0 (5.5)
· Research and development expenses MSEK 7.9 (6.6)